Pancreatitis Trial, Recruiting NCT04761523 Sponsor: University of Pecs Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT04761523
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had at least two sudden, severe episodes of pancreas inflammation (pancreatitis) in the last 2 years
  • Your most recent episode of pancreatitis had no known cause (was "idiopathic")
  • You are older than 14 years of age

Who may not be able to join:

  • You are already receiving regular dietary or nutritional guidance recommended by a doctor
  • You are in a critical or very serious medical condition, or have a terminal cancer diagnosis with a life expectancy of less than 2 years
  • You are currently receiving treatment for an active cancer
  • You have diabetes that is not well controlled — this includes if you have not been following your diabetes treatment, have certain blood sugar test results above a set level, or have been newly diagnosed with diabetes (confirm with trial site)
  • You have gallstones in your gallbladder
  • You are currently pregnant or breastfeeding
  • Your Body Mass Index (BMI — a measure of body weight relative to height) is below 18.5, which is considered underweight
  • You regularly take steroid medications (such as prednisone or cortisone) by mouth or injection
  • You drink more alcohol than the following amounts: for men, more than 5 drinks in a day or 15 drinks in a week; for women, more than 4 drinks in a day or 8 drinks in a week

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Péter Hegyi, MD, PhD, DSc, Insitute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary

Phone: +36703751031

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Pecs
Registry
ClinicalTrials.gov
Start date
1 May 2022
Est. completion
31 December 2024

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Occurrence of recurrent acute pancreatitis and/or all-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov